Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients

Fabio Lugoboni; Antonio Mirijello; Laura Morbioli; Marco Faccini; Rebecca Casari; Salvatore De Cosmo; Antonio Gasbarrini; Giovanni Addolorato

doi:10.1080/14740338.2019.1628216

Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients

Fabio Lugoboni
, Antonio Mirijello
, Laura Morbioli
, Marco Faccini
, Rebecca Casari
, Salvatore De Cosmo
, Antonio Gasbarrini
, Giovanni Addolorato^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

3 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	753-758
Numero di pagine	6
Rivista	Expert Opinion on Drug Safety
Volume	18
Numero di pubblicazione	8
DOI	https://doi.org/10.1080/14740338.2019.1628216
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Farmacologia (medica)

Keywords

Adult
Alanine Transaminase
Aspartate Aminotransferases
Chemical and Drug Induced Liver Injury
DILI
Dose-Response Relationship
Drug
Female
HDU
Humans
Liver Function Tests
Male
Middle Aged
Pharmaceutical
Prevalence
Retrospective Studies
Sleep Aids
Substance-Related Disorders
Z-Drugs
Zolpidem
abuse
dependence

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1080/14740338.2019.1628216

Altri file e collegamenti

Cita questo

@article{ea4868315432480aa1412b9ef68b0202,

title = "Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients",

abstract = "N/A",

keywords = "Adult, Alanine Transaminase, Aspartate Aminotransferases, Chemical and Drug Induced Liver Injury, DILI, Dose-Response Relationship, Drug, Female, HDU, Humans, Liver Function Tests, Male, Middle Aged, Pharmaceutical, Prevalence, Retrospective Studies, Sleep Aids, Substance-Related Disorders, Z-Drugs, Zolpidem, abuse, dependence, Adult, Alanine Transaminase, Aspartate Aminotransferases, Chemical and Drug Induced Liver Injury, DILI, Dose-Response Relationship, Drug, Female, HDU, Humans, Liver Function Tests, Male, Middle Aged, Pharmaceutical, Prevalence, Retrospective Studies, Sleep Aids, Substance-Related Disorders, Z-Drugs, Zolpidem, abuse, dependence",

author = "Fabio Lugoboni and Antonio Mirijello and Laura Morbioli and Marco Faccini and Rebecca Casari and \{De Cosmo\}, Salvatore and Antonio Gasbarrini and Giovanni Addolorato",

year = "2019",

doi = "10.1080/14740338.2019.1628216",

language = "English",

volume = "18",

pages = "753--758",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients

AU - Lugoboni, Fabio

AU - Mirijello, Antonio

AU - Morbioli, Laura

AU - Faccini, Marco

AU - Casari, Rebecca

AU - De Cosmo, Salvatore

AU - Gasbarrini, Antonio

AU - Addolorato, Giovanni

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - Adult

KW - Alanine Transaminase

KW - Aspartate Aminotransferases

KW - Chemical and Drug Induced Liver Injury

KW - DILI

KW - Dose-Response Relationship

KW - Drug

KW - Female

KW - HDU

KW - Humans

KW - Liver Function Tests

KW - Male

KW - Middle Aged

KW - Pharmaceutical

KW - Prevalence

KW - Retrospective Studies

KW - Sleep Aids

KW - Substance-Related Disorders

KW - Z-Drugs

KW - Zolpidem

KW - abuse

KW - dependence

KW - Adult

KW - Alanine Transaminase

KW - Aspartate Aminotransferases

KW - Chemical and Drug Induced Liver Injury

KW - DILI

KW - Dose-Response Relationship

KW - Drug

KW - Female

KW - HDU

KW - Humans

KW - Liver Function Tests

KW - Male

KW - Middle Aged

KW - Pharmaceutical

KW - Prevalence

KW - Retrospective Studies

KW - Sleep Aids

KW - Substance-Related Disorders

KW - Z-Drugs

KW - Zolpidem

KW - abuse

KW - dependence

UR - https://publicatt.unicatt.it/handle/10807/148522

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85067517695&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067517695&origin=inward

U2 - 10.1080/14740338.2019.1628216

DO - 10.1080/14740338.2019.1628216

M3 - Article

SN - 1474-0338

VL - 18

SP - 753

EP - 758

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

IS - 8

ER -

Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo